Menu
Close
Close
Industries

Healthcare

Our leading imaging capabilities are accelerating the discovery and development of new medicines and therapies to deliver patient benefit as soon as possible

We are improving quality of life in the UK for an ageing population

The ageing population means that the average person can expect to live well into their seventies and beyond, but with this comes rising rates of rates of cancer, heart disease and diabetes. Modern health care is under threat from the rise of drug-resistant infections, such as MRSA, salmonella and gonorrhoea, which can only be halted by more accurate diagnosis of infections, smarter use of existing drugs and the development of new ones. 

Earlier diagnosis of diseases and peronalised treatment can improve the quality of life for patients, as well as increase the likelihood of complete recovery. Our imaging techniques are constantly improving the chances of tumour detection, and more focused beams are making treatment more effective with few side effects. Drug development is still expensive and painstaking, but our understanding of how the drug is acting means the chance of developing effective drugs can be increased.   

Contact us

Improving quality of life and life expectancy in diabetes

Find out how we have exploited our knowledge and world-leading expertise in thermal imaging to reduce the occurance of foot ulcers in diabetic patients.  

Case study

Quantifying dosage and creating innovation in radiopharmaceuticals

Article

Case study

Saving lives through early foot ulcer detection

Article

Case study

Validation of new MRI standard, advancing potential technique for Alzheimer’s diagnosis

Article

Our research

Our research ranges from developing new imaging techniques to understanding how drugs actually work.

Find out how we can help you

Working with us opens the door to state-of-the-art facilities and over 500 passionate scientists with world-class measurement capabilities.